Annual report and financial statements 2015 16 95 9 Share-based payments continued 9.5 Restricted share award continued 2016 2015 Share awards Share awards thousands thousands Movement in outstanding share awards Outstanding at start of period 2,340 4,926 Exercised 1,808 2,453 Lapsed 531 133 Outstanding at end of period 1 2,340 9.6 Deferred share bonus plan Certain members of senior management participate in the deferred share bonus plan under which 50% of any bonus payable is deferred in shares for three years from the date the deferred share award is made.
Dividend equivalents accrue over the vesting period, to be paid when the shares vest.
Vesting of these share awards is subject only to service conditions.
The fair value of awards granted and the inputs used to determine it: Grant date 2015 16 scheme 2014 15 scheme Share price at grant date 2.05 2.10 Assumed leavers Exercise price nil nil Fair value of share awards granted 1.1m 0.6m 2016 2015 Share awards Share awards thousands thousands Movement in outstanding share awards Outstanding at start of period 815 937 Granted 559 286 Exercised 432 408 Lapsed 529 Outstanding at end of period 413 815 The weighted average remaining contractual life of the share awards is 1.9 years 2015: 0.9 years.
10 Other 10.1 Related party transactions The Groups related party transactions in the period include the remuneration of the senior managers note 1.7, and the Directors emoluments and pension entitlements, share awards and share options in the audited section of the Directors remuneration report, which forms part of these financial statements.
During the year, the Group received a dividend of 8m 2015: nil from MHE JVCo.
The Group owns 50% of the equity of MHE JVCo.
10.2 Post balance sheet events Following IAS 10 Events after the Balance Sheet Date, the Group continues to disclose events that it considers material and non-disclosure of which can influence the economic decisions of users of the financial statements.
On 22 February 2016, the Group repaid its $250m USPP facility of 174m which was due to mature in November 2026.
The Directors consider this event as a non-adjusting post balance sheet event.
